Once the images were captured, researchers evaluated them through a new process that could identify certain outer regions in the retina that corresponded better to brain damage and cognitive standing. Researchers saw images in which patients had an increased buildup of retinal amyloid protein. That indicated a higher possibility of developing cognitive impairments or Alzheimer’s disease.
Referring to the Cedars-Sinai research and another study involving lab mice that was recently published in the journal “Aging Cell,” Dr. Keith Black remarked on how they can impact future studies.
“This work may guide future brain and retinal imaging studies to detect Alzheimer’s disease, assess disease progression and identify first-ever treatment options,” the professor and chair of the Department of Neurosurgery said.
The findings come days after research from a University of Missouri was announced, in which assistant professor in the MU School of Health Professions Andrew Kiselica, reviewed data from the National Alzheimer’s Coordinating Center and particularly focused on the patients that had a buildup of amyloid plaque in the brain. His research showed that patients who had the buildup were more likely to show Alzheimer’s-related symptoms as compared to patients who had none.